Marie Roskrow
Chairman presso ARCTICZYMES TECHNOLOGIES ASA
Patrimonio netto: - $ in data 31/03/2024
Profilo
Marie Roskrow is currently the Executive Chairman at ArcticZymes Technologies ASA and the Chairman at Lytix Biopharma AS.
Previously, she served as the Chief Executive Officer, Executive Director, and Managing Director at Patrys Ltd.
from 2012 to 2014.
She also held the positions of Chairman and Chief Executive Officer at Helmholtz Zentrum München.
and.
ImevaX GmbH.
Dr. Roskrow obtained her undergraduate and doctorate degrees from the University of London.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Marie Roskrow
| Società | Posizione | Inizio |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Chairman | - |
| LYTIX BIOPHARMA | Chairman | 18/04/2023 |
Precedenti posizioni note di Marie Roskrow
| Società | Posizione | Fine |
|---|---|---|
| PATRYS LIMITED | Chief Executive Officer | 29/10/2014 |
Helmholtz Zentrum München
 Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Chief Executive Officer | - |
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Chief Executive Officer | - |
Formazione di Marie Roskrow
| University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PATRYS LIMITED | Health Technology |
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| LYTIX BIOPHARMA | Health Technology |
| Aziende private | 2 |
|---|---|
Helmholtz Zentrum München
Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Commercial Services |
ImevaX GmbH
ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Health Technology |
- Borsa valori
- Insiders
- Marie Roskrow
